Fractyl Health receives FDA BDD for Revita System
PremiumThe FlyFractyl Health receives FDA BDD for Revita System
3M ago
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
Premium
The Fly
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
4M ago
Fractyl Health price target lowered to $22 from $26 at BofA
Premium
The Fly
Fractyl Health price target lowered to $22 from $26 at BofA
4M ago
Fractyl Health appoints Kimber as Chief Commercial Officer
PremiumThe FlyFractyl Health appoints Kimber as Chief Commercial Officer
7M ago
Fractyl Health reports Q4 EPS ($11.18) vs ($7.39) last year
Premium
The Fly
Fractyl Health reports Q4 EPS ($11.18) vs ($7.39) last year
7M ago
Premium
Company Announcements
Fractyl Health Gains FDA Nod to Investigate Revita Device
7M ago
Fractyl Health initiated with an Outperform at Evercore ISI
PremiumThe FlyFractyl Health initiated with an Outperform at Evercore ISI
8M ago
BofA starts Fractyl Health with a Buy, sees ‘actionable catalysts’ upcoming
Premium
The Fly
BofA starts Fractyl Health with a Buy, sees ‘actionable catalysts’ upcoming
8M ago
Fractyl Health initiated with a Buy at BofA
Premium
The Fly
Fractyl Health initiated with a Buy at BofA
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100